346 related articles for article (PubMed ID: 19687510)
1. von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.
Zhao BQ; Chauhan AK; Canault M; Patten IS; Yang JJ; Dockal M; Scheiflinger F; Wagner DD
Blood; 2009 Oct; 114(15):3329-34. PubMed ID: 19687510
[TBL] [Abstract][Full Text] [Related]
2. ADAMTS13 reduces VWF-mediated acute inflammation following focal cerebral ischemia in mice.
Khan MM; Motto DG; Lentz SR; Chauhan AK
J Thromb Haemost; 2012 Aug; 10(8):1665-71. PubMed ID: 22712744
[TBL] [Abstract][Full Text] [Related]
3. Endothelial Cell-Derived von Willebrand Factor Is the Major Determinant That Mediates von Willebrand Factor-Dependent Acute Ischemic Stroke by Promoting Postischemic Thrombo-Inflammation.
Dhanesha N; Prakash P; Doddapattar P; Khanna I; Pollpeter MJ; Nayak MK; Staber JM; Chauhan AK
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1829-37. PubMed ID: 27444201
[TBL] [Abstract][Full Text] [Related]
4. Recombinant ADAMTS13 reduces tissue plasminogen activator-induced hemorrhage after stroke in mice.
Wang L; Fan W; Cai P; Fan M; Zhu X; Dai Y; Sun C; Cheng Y; Zheng P; Zhao BQ
Ann Neurol; 2013 Feb; 73(2):189-98. PubMed ID: 23280993
[TBL] [Abstract][Full Text] [Related]
5. ADAMTS13 gene deletion aggravates ischemic brain damage: a possible neuroprotective role of ADAMTS13 by ameliorating postischemic hypoperfusion.
Fujioka M; Hayakawa K; Mishima K; Kunizawa A; Irie K; Higuchi S; Nakano T; Muroi C; Fukushima H; Sugimoto M; Banno F; Kokame K; Miyata T; Fujiwara M; Okuchi K; Nishio K
Blood; 2010 Feb; 115(8):1650-3. PubMed ID: 19965676
[TBL] [Abstract][Full Text] [Related]
6. Use of a mouse model to elucidate the phenotypic effects of the von Willebrand factor cleavage mutants, Y1605A/M1606A and R1597W.
Pruss CM; Golder M; Bryant A; Hegadorn C; Haberichter S; Lillicrap D
J Thromb Haemost; 2012 May; 10(5):940-50. PubMed ID: 22372972
[TBL] [Abstract][Full Text] [Related]
7. Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.
De Meyer SF; Savchenko AS; Haas MS; Schatzberg D; Carroll MC; Schiviz A; Dietrich B; Rottensteiner H; Scheiflinger F; Wagner DD
Blood; 2012 Dec; 120(26):5217-23. PubMed ID: 22915644
[TBL] [Abstract][Full Text] [Related]
8. An IAP retrotransposon in the mouse ADAMTS13 gene creates ADAMTS13 variant proteins that are less effective in cleaving von Willebrand factor multimers.
Zhou W; Bouhassira EE; Tsai HM
Blood; 2007 Aug; 110(3):886-93. PubMed ID: 17426255
[TBL] [Abstract][Full Text] [Related]
9. ADAMTS13 gene deletion enhances plasma high-mobility group box1 elevation and neuroinflammation in brain ischemia-reperfusion injury.
Fujioka M; Nakano T; Hayakawa K; Irie K; Akitake Y; Sakamoto Y; Mishima K; Muroi C; Yonekawa Y; Banno F; Kokame K; Miyata T; Nishio K; Okuchi K; Iwasaki K; Fujiwara M; Siesjö BK
Neurol Sci; 2012 Oct; 33(5):1107-15. PubMed ID: 22212812
[TBL] [Abstract][Full Text] [Related]
10. Interplay between ADAMTS13 and von Willebrand factor in inherited and acquired thrombotic microangiopathies.
Soejima K; Nakagaki T
Semin Hematol; 2005 Jan; 42(1):56-62. PubMed ID: 15662617
[TBL] [Abstract][Full Text] [Related]
11. ADAMTS13 controls vascular remodeling by modifying VWF reactivity during stroke recovery.
Xu H; Cao Y; Yang X; Cai P; Kang L; Zhu X; Luo H; Lu L; Wei L; Bai X; Zhu Y; Zhao BQ; Fan W
Blood; 2017 Jul; 130(1):11-22. PubMed ID: 28428179
[TBL] [Abstract][Full Text] [Related]
12. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
Bao J; Xiao J; Mao Y; Zheng XL
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
[TBL] [Abstract][Full Text] [Related]
13. Changes in von Willebrand factor-cleaving protease (ADAMTS13) activity after infusion of desmopressin.
Reiter RA; Knöbl P; Varadi K; Turecek PL
Blood; 2003 Feb; 101(3):946-8. PubMed ID: 12393734
[TBL] [Abstract][Full Text] [Related]
14. Cloning, expression, and functional characterization of the von Willebrand factor-cleaving protease (ADAMTS13).
Plaimauer B; Zimmermann K; Völkel D; Antoine G; Kerschbaumer R; Jenab P; Furlan M; Gerritsen H; Lämmle B; Schwarz HP; Scheiflinger F
Blood; 2002 Nov; 100(10):3626-32. PubMed ID: 12393399
[TBL] [Abstract][Full Text] [Related]
15. Binding of ADAMTS13 to von Willebrand factor.
Majerus EM; Anderson PJ; Sadler JE
J Biol Chem; 2005 Jun; 280(23):21773-8. PubMed ID: 15824096
[TBL] [Abstract][Full Text] [Related]
16. Von Willebrand factor and ADAMTS13 in arterial thrombosis: a systematic review and meta-analysis.
Sonneveld MA; de Maat MP; Leebeek FW
Blood Rev; 2014 Jul; 28(4):167-78. PubMed ID: 24825749
[TBL] [Abstract][Full Text] [Related]
17. Delayed treatment with ADAMTS13 ameliorates cerebral ischemic injury without hemorrhagic complication.
Nakano T; Irie K; Hayakawa K; Sano K; Nakamura Y; Tanaka M; Yamashita Y; Satho T; Fujioka M; Muroi C; Matsuo K; Ishikura H; Futagami K; Mishima K
Brain Res; 2015 Oct; 1624():330-335. PubMed ID: 26254727
[TBL] [Abstract][Full Text] [Related]
18. Keeping von Willebrand Factor under Control: Alternatives for ADAMTS13.
Tersteeg C; Fijnheer R; Pasterkamp G; de Groot PG; Vanhoorelbeke K; de Maat S; Maas C
Semin Thromb Hemost; 2016 Feb; 42(1):9-17. PubMed ID: 26595154
[TBL] [Abstract][Full Text] [Related]
19. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13.
Bowen DJ; Collins PW
Blood; 2004 Feb; 103(3):941-7. PubMed ID: 14525793
[TBL] [Abstract][Full Text] [Related]
20. Degradation of circulating von Willebrand factor and its regulator ADAMTS13 implicates secreted Bacillus anthracis metalloproteases in anthrax consumptive coagulopathy.
Chung MC; Popova TG; Jorgensen SC; Dong L; Chandhoke V; Bailey CL; Popov SG
J Biol Chem; 2008 Apr; 283(15):9531-42. PubMed ID: 18263586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
